965150

Acadia Pharmaceuticals Inc. — FEI 3005617555

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
February 17, 2016
Fiscal Year
2016
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
San Diego, CA (United States)

Additional Details

Sponsor, Contract Research Organization

Citations

IDCFRDescription
747921 CFR 312.56(a)Monitoring investigations
748221 CFR 312.50General responsibilities of sponsors